Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members

Summary Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2007-11, Vol.157 (5), p.1030-1031
Hauptverfasser: Berroeta, L., Man, I., Goudie, D.R., Whatley, S.D., Elder, G.H., Ibbotson, S.H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1031
container_issue 5
container_start_page 1030
container_title British journal of dermatology (1951)
container_volume 157
creator Berroeta, L.
Man, I.
Goudie, D.R.
Whatley, S.D.
Elder, G.H.
Ibbotson, S.H.
description Summary Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.
doi_str_mv 10.1111/j.1365-2133.2007.08117.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68382866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21058872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</originalsourceid><addsrcrecordid>eNqNkUtv3CAUhVHVKpk8_kLFpt3ZvYDBuFIXbR5No5GySdYI4-uGkR9T8Kjxvw_OjJplw4bH-e7l6hxCKIOcpfVlkzOhZMaZEDkHKHPQjJX50zuy-ie8JytIUgaVEsfkJMYNABMg4Ygcs7JkTHK5Iu3aTki3ASMOk538ONCxpRjm6TGM29Hj5F2SxyldwvZxDt5-pc5GpAHTy0Tt0NDfOLxwdrDdHH1cWrS2991Me-xrDPGMfGhtF_H8sJ-Sh-ur-4ubbH3389fF93XmiqooM42K11wXyHTRFuBaIXWJWEnGwEFdoVO1FNyVqqhr2whwNXDZNIXmSjthxSn5vO-bRv6zwziZ3keHXWcHHHfRKC0010r9F-QMpNYlT6Degy6MMQZszTb43obZMDBLGGZjFs_N4rlZwjAvYZinVPrx8Meu7rF5LTy4n4BPB8BGZ7s22MH5-MpVrNICIHHf9txf3-H85gHMj9vL5SSeAXH0pks</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21058872</pqid></control><display><type>article</type><title>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Berroeta, L. ; Man, I. ; Goudie, D.R. ; Whatley, S.D. ; Elder, G.H. ; Ibbotson, S.H.</creator><creatorcontrib>Berroeta, L. ; Man, I. ; Goudie, D.R. ; Whatley, S.D. ; Elder, G.H. ; Ibbotson, S.H.</creatorcontrib><description>Summary Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/j.1365-2133.2007.08117.x</identifier><identifier>PMID: 17711525</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Age of Onset ; Biological and medical sciences ; Dermatology ; erythropoietic protoporphyria ; Female ; ferrochelatase ; Ferrochelatase - genetics ; ferrochelatase mutations ; Genotype ; Humans ; inheritance ; Medical sciences ; Metabolic diseases ; Middle Aged ; Other metabolic disorders ; Photosensitivity Disorders - etiology ; Pigments (porphyrias, hyperbilirubinemias...) ; porphyrins ; Protoporphyria, Erythropoietic - complications ; Protoporphyria, Erythropoietic - diagnosis ; Protoporphyria, Erythropoietic - genetics ; Skin involvement in other diseases. Miscellaneous. General aspects</subject><ispartof>British journal of dermatology (1951), 2007-11, Vol.157 (5), p.1030-1031</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</citedby><cites>FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2133.2007.08117.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2133.2007.08117.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19198300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17711525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berroeta, L.</creatorcontrib><creatorcontrib>Man, I.</creatorcontrib><creatorcontrib>Goudie, D.R.</creatorcontrib><creatorcontrib>Whatley, S.D.</creatorcontrib><creatorcontrib>Elder, G.H.</creatorcontrib><creatorcontrib>Ibbotson, S.H.</creatorcontrib><title>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Summary Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.</description><subject>Age of Onset</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>erythropoietic protoporphyria</subject><subject>Female</subject><subject>ferrochelatase</subject><subject>Ferrochelatase - genetics</subject><subject>ferrochelatase mutations</subject><subject>Genotype</subject><subject>Humans</subject><subject>inheritance</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Middle Aged</subject><subject>Other metabolic disorders</subject><subject>Photosensitivity Disorders - etiology</subject><subject>Pigments (porphyrias, hyperbilirubinemias...)</subject><subject>porphyrins</subject><subject>Protoporphyria, Erythropoietic - complications</subject><subject>Protoporphyria, Erythropoietic - diagnosis</subject><subject>Protoporphyria, Erythropoietic - genetics</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv3CAUhVHVKpk8_kLFpt3ZvYDBuFIXbR5No5GySdYI4-uGkR9T8Kjxvw_OjJplw4bH-e7l6hxCKIOcpfVlkzOhZMaZEDkHKHPQjJX50zuy-ie8JytIUgaVEsfkJMYNABMg4Ygcs7JkTHK5Iu3aTki3ASMOk538ONCxpRjm6TGM29Hj5F2SxyldwvZxDt5-pc5GpAHTy0Tt0NDfOLxwdrDdHH1cWrS2991Me-xrDPGMfGhtF_H8sJ-Sh-ur-4ubbH3389fF93XmiqooM42K11wXyHTRFuBaIXWJWEnGwEFdoVO1FNyVqqhr2whwNXDZNIXmSjthxSn5vO-bRv6zwziZ3keHXWcHHHfRKC0010r9F-QMpNYlT6Degy6MMQZszTb43obZMDBLGGZjFs_N4rlZwjAvYZinVPrx8Meu7rF5LTy4n4BPB8BGZ7s22MH5-MpVrNICIHHf9txf3-H85gHMj9vL5SSeAXH0pks</recordid><startdate>200711</startdate><enddate>200711</enddate><creator>Berroeta, L.</creator><creator>Man, I.</creator><creator>Goudie, D.R.</creator><creator>Whatley, S.D.</creator><creator>Elder, G.H.</creator><creator>Ibbotson, S.H.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200711</creationdate><title>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</title><author>Berroeta, L. ; Man, I. ; Goudie, D.R. ; Whatley, S.D. ; Elder, G.H. ; Ibbotson, S.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4947-8e62b284e184f40cf3587ee95110c0b9ec6b532c764bbad30cb025dd48268c3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Age of Onset</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>erythropoietic protoporphyria</topic><topic>Female</topic><topic>ferrochelatase</topic><topic>Ferrochelatase - genetics</topic><topic>ferrochelatase mutations</topic><topic>Genotype</topic><topic>Humans</topic><topic>inheritance</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Middle Aged</topic><topic>Other metabolic disorders</topic><topic>Photosensitivity Disorders - etiology</topic><topic>Pigments (porphyrias, hyperbilirubinemias...)</topic><topic>porphyrins</topic><topic>Protoporphyria, Erythropoietic - complications</topic><topic>Protoporphyria, Erythropoietic - diagnosis</topic><topic>Protoporphyria, Erythropoietic - genetics</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berroeta, L.</creatorcontrib><creatorcontrib>Man, I.</creatorcontrib><creatorcontrib>Goudie, D.R.</creatorcontrib><creatorcontrib>Whatley, S.D.</creatorcontrib><creatorcontrib>Elder, G.H.</creatorcontrib><creatorcontrib>Ibbotson, S.H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berroeta, L.</au><au>Man, I.</au><au>Goudie, D.R.</au><au>Whatley, S.D.</au><au>Elder, G.H.</au><au>Ibbotson, S.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2007-11</date><risdate>2007</risdate><volume>157</volume><issue>5</issue><spage>1030</spage><epage>1031</epage><pages>1030-1031</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>Summary Erythropoietic protoporphyria (EPP) is an inherited disorder of haem biosynthesis caused by decreased activity of the enzyme ferrochelatase (FECH), which catalyses the insertion of iron into protoporphyrin, the last step in haem biosynthesis. Development of clinically overt EPP usually requires inheritance of a severe FECH mutation trans to a low‐expression FECH variant (FECH IVS3‐48C), which is present in 13% of the U.K. population. Reduced FECH activity leads to accumulation of protoporphyrin in various tissues. An excess amount of free protoporphyrin in the skin causes photosensitivity. EPP usually presents in early childhood or infancy, with painful burning and pruritus within minutes of light exposure. Onset of symptoms in adults is rare and often associated with acquired somatic mutation of the FECH gene secondary to haematological malignancy. Here we describe a patient with EPP, in whom the presenting clinical symptom, night‐time itch, did not appear until middle age and who had an asymptomatic sister with the same FECH genotype.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17711525</pmid><doi>10.1111/j.1365-2133.2007.08117.x</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 2007-11, Vol.157 (5), p.1030-1031
issn 0007-0963
1365-2133
language eng
recordid cdi_proquest_miscellaneous_68382866
source MEDLINE; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current)
subjects Age of Onset
Biological and medical sciences
Dermatology
erythropoietic protoporphyria
Female
ferrochelatase
Ferrochelatase - genetics
ferrochelatase mutations
Genotype
Humans
inheritance
Medical sciences
Metabolic diseases
Middle Aged
Other metabolic disorders
Photosensitivity Disorders - etiology
Pigments (porphyrias, hyperbilirubinemias...)
porphyrins
Protoporphyria, Erythropoietic - complications
Protoporphyria, Erythropoietic - diagnosis
Protoporphyria, Erythropoietic - genetics
Skin involvement in other diseases. Miscellaneous. General aspects
title Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T02%3A01%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20presentation%20of%20erythropoietic%20protoporphyria:%20case%20report%20and%20genetic%20analysis%20of%20family%20members&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Berroeta,%20L.&rft.date=2007-11&rft.volume=157&rft.issue=5&rft.spage=1030&rft.epage=1031&rft.pages=1030-1031&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1111/j.1365-2133.2007.08117.x&rft_dat=%3Cproquest_cross%3E21058872%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21058872&rft_id=info:pmid/17711525&rfr_iscdi=true